25 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Compared to Estimates, Philip Morris (PM) Q4 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2223534/compared-to-estimates-philip-morris-pm-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2223534 Feb 08, 2024 - While the top- and bottom-line numbers for Philip Morris (PM) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Jobless Claims Steady; Mixed Q4 for AZN, HSY and PM https://www.zacks.com/stock/news/2223512/jobless-claims-steady-mixed-q4-for-azn-hsy-and-pm?cid=CS-ZC-FT-ahead_of_wall_street-2223512 Feb 08, 2024 - We're once again reassured that employment, on a finer week-over-week scale, is not falling off a cliff.
Earnings Season Scorecard and Analyst Reports for Thermo Fisher, Philip Morris & General Dynamics https://www.zacks.com/commentary/2221807/earnings-season-scorecard-and-analyst-reports-for-thermo-fisher-philip-morris-general-dynamics?cid=CS-ZC-FT-research_daily-2221807 Feb 06, 2024 - Today's Research Daily features the real-time earnings season scorecard and updated analyst reports on Thermo Fisher (TMO), Philip Morris International (PM) and General Dynamics (GD).
What Analyst Projections for Key Metrics Reveal About Philip Morris (PM) Q4 Earnings https://www.zacks.com/stock/news/2220920/what-analyst-projections-for-key-metrics-reveal-about-philip-morris-pm-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220920 Feb 05, 2024 - Besides Wall Street's top -and-bottom-line estimates for Philip Morris (PM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Philip Morris (PM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release https://www.zacks.com/stock/news/2219565/philip-morris-pm-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2219565 Feb 01, 2024 - Philip Morris (PM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is British American Tobacco's 9.5% Dividend Yield Too Good to Be True? https://www.fool.com/investing/2024/01/21/is-british-american-tobaccos-95-dividend-yield-too/?source=iedfolrf0000001 Jan 21, 2024 - The cigarette company has one of the highest yields on the market.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now https://www.zacks.com/stock/news/2207962/why-investors-need-to-take-advantage-of-these-2-consumer-staples-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2207962 Jan 09, 2024 - Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Will Philip Morris (PM) Beat Estimates Again in Its Next Earnings Report? https://www.zacks.com/stock/news/2207738/will-philip-morris-pm-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2207738 Jan 09, 2024 - Philip Morris (PM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights Merck, Salesforce, Philip Morris International, Novartis and CME Group https://www.zacks.com/stock/news/2206930/the-zacks-analyst-blog-highlights-merck-salesforce-philip-morris-international-novartis-and-cme-group?cid=CS-ZC-FT-press_releases-2206930 Jan 08, 2024 - Merck, Salesforce, Philip Morris International, Novartis and CME Group are part of the Zacks top Analyst Blog.
Top Analyst Reports for Merck, Salesforce & Philip Morris https://www.zacks.com/commentary/2206306/top-analyst-reports-for-merck-salesforce-philip-morris?cid=CS-ZC-FT-research_daily-2206306 Jan 05, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Salesforce, Inc. (CRM) and Philip Morris International Inc. (PM).

Pages: 123

<Page 2